The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases

Details for Australian Patent Application No. 2006224842 (hide)

Owner MEDA Pharma GmbH & Co KG

Inventors Fyrnys, Beatrix; Munzel, Ullrich; Cnota, Peter Jurgen; Weingart, Mario; Petzold, Ursula; Maus, Joachim; Szelenyi, Istvan; Hoffmann, Torsten

Agent Spruson & Ferguson

Pub. Number AU-B-2006224842

PCT Pub. Number WO2006/097250

Priority 60/661,918 16.03.05 US

Filing date 10 March 2006

Wipo publication date 21 September 2006

Acceptance publication date 29 September 2011

International Classifications

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/47 (2006.01) - Quinolines

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

16 August 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/097250 Priority application(s): WO2006/097250

29 September 2011 Application Accepted

  Published as AU-B-2006224842

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224851-Ammonia-free oxidation dye for dyeing keratin fibers with atmospheric oxygen serving as the sole oxidizing agent

2006224816-Novel resorcinol derivatives for skin